Barinthus Biotherapeutics's total assets for Q4 2025 were $98.17M, a decrease of -10.10% from the previous quarter. BRNS total liabilities were $23.88M for the fiscal quarter, a -3.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.